The Use of Localised Vaginal Drug Delivery as Part of a Neoadjuvant Chemotherapy Strategy in the Treatment of Cervical Cancer
Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2015, Vol 2, Issue 1
Abstract
Cervical cancer is the third most prevalent cancer in women globally, with 529,000 diagnosis and 275,000 deaths each year. It is especially prevalent in developing countries where approximately 85% of cases arise due to the lack of cervical cancer prevention and control programs. In developed countries, where women have access to resources capable of detecting and treating precancerous lesions, the number of cases is reduced by approximately 80%.1 Cervical cancer can be characterised, depending on how far it has spread, from stage 0 (precancerous), also called Cervical Intraepithelial Neoplasia (CIN), where abnormal cells are found in the innermost lining of the cervix and have the potential to become cancerous, through to stage 4, where the cancer has spread to the bladder, rectum or other parts of the body, such as the lungs. In developed countries, there are currently two methods used to prevent cervical cancer from developing to an advanced stage: (1) the distribution of HPV vaccines that are mainly directed against HPV types 16 and 182 and (2) screening methods, such as Papanicolaou test (Pap smear), which involves the collection of exfoliated cells from the cervix, which are then examined for cellular abnormalities. This enables identification of CIN before they begin to develop into cervical cancer.
Authors and Affiliations
Christopher McConville
Keywords
Related Articles
- EP ID EP553476
- DOI 10.17140/GOROJ-2-106
- Views 193
- Downloads 0
Assessment of Maternal Nifedipine as a Tocolytic Agent on the Doppler Indices of Uterine and Fetal Umbilical and Middle Cerebral Arteries
Objective: This study was designed to assess the effects of maternal nifedipine administration on blood flow resistance in uterine, umbilical and fetal middle cerebral arteries by evaluating resistance index (RI) and pul...
Developmental Exposure to Endocrine Disrupting Chemicals Alters the Epigenome: Identification of Reprogrammed Targets
Endocrine disruptions induced by environmental toxicants have placed an immense burden on society to properly diagnose, treat and attempt to alleviate symptoms and disease. Environmental exposures during critical periods...
Competing Endoscopic Surgeries in the Era of Assisted Reproductive Technologies: Evidence and Practice
Now-a-days the assisted reproductive technologies (ART) are progressing and advancing rapidly. Many reproductive medicine specialists do believe in ART to be the first choice for infertile women regardless of age related...
Post-Operative Outcomes of Oxidized Regenerated Cellulose Use in Women Undergoing Cesarean Delivery
Introduction: In spite of careful technique, bleeding may continue to occur at time of surgery. Absorbable hemostatic agents have been developed in order to control hemorrhage. However, no study to date has investigated...
Interactions of Immunomodulatory HLA-G with Immune Cells during Pregnancy and Endometriosis
The Major Histocompatibility Complex (MHC), the genetic region that encodes the proteins responsible for tissue graft rejection,1 encodes MHC Class I (MHC-I) and MHC Class II (MHC-II) glycoproteins. There are two subclas...